Ibex Medical Analytics uses artificial intelligence technology to develop clinical-grade solutions designed to detect cancer as accurately as a human pathologist. The companys Galen platform uses algorithms to analyze images, detect and grade cancer in biopsies, and point to other findings with high clinical importance, helping pathologists to reduce diagnostic error rates and enable a more efficient workflow. Deployed worldwide, Ibexs Galen Prostate and Galen Breast are AI-based cancer detection solutions used in routine clinical practice in pathology labs, with demonstrated success in detecting missed cancer cases. In addition, the company is developing computational prognostic and predictive tests that will enable enhanced patient population stratification and quicker personalized treatment selection.